business

Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

Yahoo Finance · Jun 23, 2026, 7:39 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Morgan Stanley upgrades Qualcomm stock rating on data center guidance Investing.com Morgan Stanley upgrades Sonova stock rating on hearing aid market growth Investing.com Morgan Stanley Names Top U.S. Beverage Stock Pick Bloomberg Markets Morgan Stanley Caps Private Credit Fund After 11.6% Exit Request

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

Also covered by

More in business